npj Aging

Tumor mutation patterns differed with age across cancer types

Across 13 cancer subtypes, a cross-sectional computational analysis linked patient age to differences in tumor mutations and in which mutations occurred together.

Our read

Mechanisms
Studied:
Cross-sectional study of people with cancer (Independent replication)
What changed:
Tumor mutation patterns differed by age and cancer type, with some mutations more common in older patients
The catch:
Changes in mutations as individual patients aged were not measured
In the record:
One of 3 papers on PTPRT on record: 1 with results in people.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In people with brain, breast, colorectal, lung, pancreatic or skin cancer, researchers examined links between age and tumor mutations, or DNA changes. Their cross-sectional computational analysis covered 13 cancer subtypes. They used publicly available clinical and tumor DNA data, mainly from the American Association for Cancer Research’s Project GENIE database, alongside separate breast cancer datasets.

The age-related patterns differed by cancer type and gene. Some mutations were more common in older patients; others peaked at younger ages. Associations between mutations occurring together also strengthened or weakened with age. A separate exploratory analysis of 240 non-small cell lung cancer samples suggested that links between mutations and time without cancer progression might vary with age among people receiving drugs that help the immune system attack cancer.

Why it matters

Cancer becomes more common with age. The work raises the question of whether particular tumor mutations may relate differently to treatment outcomes in younger and older patients.

Caveats

The cross-sectional analysis compared different patients, so it cannot show that aging caused the mutation patterns. None of the exploratory treatment-outcome associations remained statistically significant after correction for multiple comparisons.

Comments

Be the first to comment.